Trial intelligence / Profile preview

Enzira versus GSK influenza vaccine in healthy adults aged 65 years and older

2006-004354-24Phase 4Terminated

Sponsor
CSL Limited
Start
Sep 2006
Modality
Small Molecules, Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of omeprazole and Fluarix in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Seroprotection rate, Seroconversion rate and 1 more. Started Sep 2006; status: terminated.

02

Drugs

omeprazoleFluarix
03

Conditions

influenza

Beyond the preview

Go deeper on 2006-004354-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004354-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call